Which medications in the drug class Topical Alpha Agonists are used in the treatment of Rosacea?

Updated: Jun 03, 2021
  • Author: Agnieszka Kupiec Banasikowska, MD; Chief Editor: William D James, MD  more...
  • Print

Topical Alpha Agonists

Topical alpha1 and alpha 2 agonists have been approved by the FDA to treat rosacea.

Oxymetazoline topical (Rhofade)

Oxymetazoline topical is an alpha1 agonist that elicits vasoconstriction of the cutaneous microvasculature. It is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.

Brimonidine topical (Mirvaso)

Brimonidine is an alpha-2 adrenergic agonist. It is indicated for persistent facial erythema of rosacea in adults.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!